COVID-19 Impact on Cancer Patient Outcomes
Summary
The convergence of SARS-CoV-2 infection and oncological disease has revealed that patients with cancer bear a disproportionate burden from COVID-19. Immune dysregulation induced by malignancy and anticancer therapies amplifies susceptibility to severe infection, leading to higher rates of hospitalisation, intensive care admission and mortality compared with the general population. Moreover, interruption of systemic anticancer therapy owing to infection or resource constraints has compromised tumour control and long-term survival. The emergence of viral variants and the rollout of vaccination campaigns have further shaped outcomes: vaccine uptake has been shown to reduce post-COVID sequelae and facilitate continuity of care, while novel variants have variably influenced disease severity in this vulnerable group. Regional and registry studies have underscored the importance of tailored risk stratification—incorporating tumour type, treatment history and comorbidities—to guide protective measures, vaccination prioritisation and therapeutic decision-making. This global challenge has prompted innovation in telemedicine and adaptive treatment protocols aimed at safeguarding patients while maintaining optimal oncological outcomes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
COVID-19 Impact on Cancer Patient Outcomes publication trend
The graph below shows the total number of articles in covid-19 impact on cancer patient outcomes across all publications each year (not limited to Nature Index journals).
Technical terms
Sequelae: Persistent health complications following the acute phase of infection.
Systemic anticancer therapy: Treatments—such as chemotherapy, targeted agents or immunotherapy—that circulate throughout the body to combat malignancy.
Haematological malignancy: Cancer arising from blood-forming tissues, including leukaemias, lymphomas and myelomas.
Solid tumour: A mass of tissue arising from organ systems (e.g. breast, lung, colorectal) as opposed to blood cancers.
Intensive care unit (ICU): Hospital ward providing specialised life-support treatment for critically ill patients.
References
- SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. The Lancet Oncology (2023).
- Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era. The Lancet Regional Health - Europe (2023).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.